What is Greentank?
Founded in 2015 and headquartered in Ontario, Canada, Greentank has established itself as a critical infrastructure provider within the cannabis industry. By engineering vaporization technology tailored to specific extract formulations, the company bridges the gap between raw product and consumer experience. Its market position is defined by a commitment to precision manufacturing and hardware innovation, serving as a vital partner for brands seeking to differentiate their offerings through superior inhalation performance. The company's growth strategy has been supported by a series of funding rounds, evolving from early-stage backing to significant enterprise-level financing.
How much funding has Greentank raised?
Greentank has raised a total of $50.8M across 4 funding rounds:
Angel/Seed
$4.3M
Series A
$10M
Series B
$16.5M
Stock/Share Issuance
$20M
Angel/Seed (2018): $4.3M with participation from Casa Verde Capital and Green Acre Capital
Series A (2019): $10M led by Green Acre Capital and Newstrike Brands
Series B (2023): $16.5M supported by Organigram Holdings
Stock/Share Issuance (2026): $20M featuring AIR (Advanced Inhalation Rituals)
Key Investors in Greentank
Casa Verde Capital
Casa Verde is a premier venture capital firm focusing exclusively on the cannabis industry, targeting scalable and capital-efficient businesses with world-class management teams.
Green Acre Capital
Green Acre Capital is a Toronto-based private investment fund dedicated to supporting the growth and development of the Canadian cannabis sector.
AIR (Advanced Inhalation Rituals)
AIR Global is a dominant manufacturer in the social inhalation market, specializing in hookah products and electronic inhalation devices with a significant global market share.
What's next for Greentank?
With this latest infusion of capital, Greentank is positioned to accelerate its research and development initiatives, likely focusing on the next generation of vaporization hardware and potential expansion into adjacent inhalation markets. The strategic alignment with industry-leading partners suggests a focus on scaling production capacity and deepening its footprint in both domestic and international markets. As the regulatory landscape for cannabis and social inhalation products continues to mature, Greentank's ability to provide scalable, high-performance solutions will be a key determinant in its long-term market dominance and operational sustainability.
See full Greentank company page
